Insight Molecular Diagnostics Inc.

IMDX ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2022

Total Assets: $100.1M

Liabilities Breakdown FY2022

Total Liabilities: $60.5M